BioSpace News Archive

Siemens Healthineers announced today that Hospital Auxilio Mutuo in Puerto Rico has become the first hospital on the island and the first transplant center in the world to advance its laboratory testing with the Atellica® Solution

PIN Pharma, a company focused on modulating the immune system and having its first indication in oncology, today announced the Company will be presenting a poster at the 55th Annual meeting of ASCO in Chicago on June 1 between 8:00 AM – 11:00 reporting the results of the first-in-human trial evaluating the immune activation and safety of PIN-2 administered to patients with advanced solid tumors.

Since completion of the Phase 2 clinical trial, Pfizer, has been responsible for clinical development of rivipansel, including the RESET clinical trial.

These results will be presented this week during the 71st annual meeting of the American Academy of Neurology (AAN) in Philadelphia, PA.

Advances have been completed in the manufacturing process for the clinical trial product that will be used in PharmaCyte’s planned clinical trial in locally advanced, inoperable pancreatic cancer

Skyhawk will use its SkySTAR™ platform to develop drug candidates directed to multiple targets for neurodegenerative diseases. In exchange Takeda will pay Skyhawk an upfront payment, future milestone payments and royalties.

Four patients enrolled and treated by sports medicine surgeon Dr. Scott Hacker, MD

Photocure ASA announced key data presented at the 2019 American Urological Association Annual Meeting in Chicago.

Clovis Oncology, Inc. announced that Patrick J. Mahaffy, Chief Executive Officer and President, will present at the Bank of America Merrill Lynch Healthcare Conference 2019 on Tuesday, May 14, 2019 at 2:20 PM Pacific Time.

Moderna, Inc. announced that Tal Zaks, M.D., Ph.D., Chief Medical Officer, and Lorence Kim, M.D., Chief Financial Officer, will present at the Bank of America Merrill Lynch 2019 Health Care Conference on Tuesday, May 14, 2019 at 9:20 a.m. PT.